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Cells of the immune system are highly sensitive to altered gravity, and themonocyte as well as themacrophage function is proven to
be impaired under microgravity conditions. In our study, we investigated the surface expression of ICAM-1 protein and expression
of ICAM-1 mRNA in cells of the monocyte/macrophage system in microgravity during clinostat, parabolic flight, sounding rocket,
and orbital experiments. In murine BV-2 microglial cells, we detected a downregulation of ICAM-1 expression in clinorotation
experiments and a rapid and reversible downregulation in the microgravity phase of parabolic flight experiments. In contrast,
ICAM-1 expression increased inmacrophage-like differentiated humanU937 cells during themicrogravity phase of parabolic flights
and in long-termmicrogravity provided by a 2D clinostat or during the orbital SIMBOX/Shenzhou-8 mission. In nondifferentiated
U937 cells, no effect of microgravity on ICAM-1 expression could be observed during parabolic flight experiments. We conclude
that disturbed immune function in microgravity could be a consequence of ICAM-1 modulation in the monocyte/macrophage
system, which in turn could have a strong impact on the interaction with T lymphocytes and cell migration. Thus, ICAM-1 can be
considered as a rapid-reacting and sustained gravity-regulated molecule in mammalian cells.
1. Introduction
Several limiting factors for human health and performance
in microgravity have been clearly identified arising from
the immune system, and substantial research activities are
required in order to provide the basic information for appro-
priate integrated risk management. The gravity-sensitive
nature of cells of the immune system renders them an
ideal biological model in search for general gravity-sensitive
mechanisms to understandhow the architecture and function
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of human cells are related to the gravitational force and
therefore adapted to life on Earth. Cells of the immune system
are highly sensitive to altered gravity (for review see [1–
4]). T lymphocytes as well as monocytes and macrophages
are impaired severely in their functions under microgravity
conditions [2–4]. T cell activation is severely disturbed under
microgravity conditions as shown in the blood of astronauts
during and after space flight [5] and in numerous in vitro
experiments (reviewed by [6]). In monocytes the secretion
of the cytokines IL-1, IL-6, TNF-alpha, and IL-10 is altered
under microgravity conditions [7, 8]. Substantial changes in
gene expression of monocytes and in gene induction associ-
ated with the differentiation of monocytes into macrophages
have been observed [8].
Migration and adhesion of immune competent cells at
areas of infection, inflammation, or structural disorders
are indispensable for the immune response [9]. For these
processes the communication and connection between cells
are essential. The integrins of the LeuCAM family (LFA-
1 and MAC-1) and their ligands, the intercellular adhesion
molecules (ICAMs), are receptors that mediate the attach-
ment between cells (cell-cell contact) and of cells and the
extracellular matrix (cell-matrix contact) [10]. ICAMs are
transmembrane proteins that are expressed on epithelial cells,
endothelial cells, and cells of the immune system including
T cells and macrophages. Binding of ICAM-1 (CD54) to
receptors on endothelia of blood vessels enables leucocytes
to attach and migrate through the endothelia to sites of
inflammation [11]. Later on in the immune reaction close
and strong interaction between ICAM-1 and LFA-1 is indis-
pensable for the immunological synapse formation between
T cells and antigen-presenting cells such as monocytes
[12].
ICAM-1 expression is known to be upregulated during
mechanical stress [13], in a long-term microgravity envi-
ronment [14], in the NASA-developed Rotary Cell Culture
Systems (RCCS) as well as during short-term microgravity
in parabolic flights [15] in endothelial cells. While these
studies show gravity sensitivity of ICAM-1 in endothelial
cells, less is known about the effects of microgravity on cells
of the 2 monocyte/macrophage system (MMS). Therefore
in this study we investigate whether the ICAM-1 surface
expression is regulated by altered gravity in these cell types.
The MMS belongs to the innate immune system and rep-
resents the body’s first line of defense. The innate immune
system is characterized by a fast, but unspecific immune
reaction, and it activates the adaptive immune response.This
activation occurs through interaction of antigen-presenting
cells (APCs)—dendritic cells and macrophages [16]—with
T lymphocytes. Macrophages are relatively long-lived, carry
a variety of surface receptors, and reside in many tissues
including the gastrointestinal tract, the respiratory tract, the
liver, the spleen, bones, and connective tissues [17].Microglial
cells are the brain-resident macrophage population which
crucially controls and regulates immune reactions inside the
central nervous system (CNS).
In our study, we investigated the surface expression of
ICAM-1 protein and expression of ICAM-1 mRNA in cells
of the monocyte/macrophage system in microgravity. As cell
models we used primary cells (macrophages, T cells) as well
as cell lines (U937 myelomonocytic cells, macrophage-like
differentiated U937 cells, and BV-2 microglial cells). We con-
ducted experiments with different durations of microgravity
in clinorotation, parabolic flight, sounding rocket, and orbital
flight experiments.
2. Methods
2.1. U937 Cell Culture and Macrophage-Like Differentiation.
U937 cells (ATCC CRL-1593.2) are a human monocytic
cell line that preserves the main monoblastic character-
istics of monocytes including the ability to differentiate
into a macrophage-like phenotype. U937 cells were cultured
in RPMI 1640 medium with or without 20mM HEPES
(Biochrom, Berlin, Germany), supplemented with 10% fetal
calf serum (FCS, Biochrom) or 10% human serum (HS,
Biowest), 2mMglutamine (PromoCell), 100U/mLpenicillin,
and 100 𝜇g/mL streptomycin (Gibco). Subcultivation was
done at a cell density of 1 × 106 cells/mL. Stimulation
and differentiation were performed by adding 25 nM phor-
bolmyristylacetate (PMA) (Sigma-Aldrich) in dimethylsul-
foxid (DMSO, 0.1%) (Sigma-Aldrich) at a cell density of
0.5× 106 cells/mL.Differentiationmediumwas supplemented
with 10% HS, 2mM glutamine, 100U/mL penicillin, and
100 𝜇g/mL streptomycin. Cells were differentiated on poly-
carbonate (Makrolon) slides (SIMBOX/Shenzhou-8) or in
cell culture flasks (parabolic flights and clinorotation exper-
iments) for 72 h at 37∘C with 5% CO
2
into a macrophage-
like phenotype. U937macrophage-like cells were detached by
Macrophage Detachment Solution DXF (PromoCell) follow-
ing manufacturer’s protocol. After detaching, cells were filled
immediately into Nutrimix bags (B. BraunMelsungen) (1-2 ×
107 cells in 10mL medium each bag) for parabolic flight or
in serological pipettes (1mL cell suspension with 0.25–0.5 ×
106/mL) for clinorotation experiments [18, 19].
2.2. Primary Human Macrophages. Human primary M2
macrophages (PromoCell) were cultivated with M2-
Macrophage Generation Medium DXF (PromoCell). Cells
were detached by Macrophage Detachment Solution DXF
(PromoCell) following the manufacturer’s protocol. After
detaching, cells were filled immediately into Nutrimix bags
(B. Braun Melsungen) (2 × 106 cells in 10mL medium each
bag) for parabolic flight, or in serological pipettes (1mL
cell suspension with 0.25–0.5 × 106/mL) for clinorotation
experiment [18, 19].
2.3. BV-2 Microglia Cell Culture. Since primary microglia are
not available in quantities required for parabolic flight exper-
iments, we used the murine cell line BV-2, whose function
resembles that of tissue macrophages and which share many
properties with both peripheral macrophages andmonocytes
[20]. BV-2 microglial cells were cultured in DMEMmedium
(Biochrom, Berlin, Germany) supplemented with 10% FCS
and without antibiotics. 72 hours before parabolic flight
experiment, the cells were set on only 2% FCS (serum
starved) for the transport and were supplemented again
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Figure 1: Technology for cell culture experiments in different microgravity research platforms. (a) Fast-rotating two-dimensional (2D)
clinostat manufactured by the German Aerospace Center (DLR, Cologne, Germany) was used to provide simulated microgravity. Under
the chosen experimental conditions (60 rpm, 4mm pipette diameter) a maximal residual acceleration of 4 × 10−3 g is achieved at the outer
radius of the pipette and decreases towards the center. (b) Experimental hardware structure which consists of an incubator rack to store the
cell containers temporarily before the experiment at 37∘C (left), an experimental rack in which all active aggregates are accommodated and
where the living cells are handled during altered gravity (right) and a cooling rack to temporarily store all cell containers after the injection of
the stop/fixation liquid at 4∘C until landing (front). (c) Payload of TEXUS-49 sounding rocket tempered and vacuum-resistant container with
experiment syringe systems. (d) Plunger unit EUE for SIMBOX (Science in Microgravity Box) incubator system, support structure (housing
made of PEEK), which includes three culture chambers and six supply units, two for each culture compartment. Each culture chamber
represents an independent loop. The culture chambers filled with medium are closed on the top of the housing by means of polycarbonate
specimen window slides, where the adherent cells are attached beforehand. The housing is tightened by silicon sealing and covered by an
aluminum plate (cover) fixed with screws.
with 10% FCS after arrival. Before transport to Bordeaux-
Me´rignac airport, BV-2 cells were transferred into 200mL
Nutrimix bags (B. Braun Melsungen, Melsungen, Germany)
at a density of 3 × 106 cells in 15mL medium.
2.4. Experiments in Simulated Microgravity (2D Clinorota-
tion). A fast-rotating two-dimensional (2D) clinostat man-
ufactured by the German Aerospace Center (DLR, Cologne,
Germany) was used to provide simulated microgravity
(Figure 1(a)). The principle of clinorotation-induced micro-
gravity is the rotation of a cell suspension in a serological
pipette perpendicular to the Earth’s gravity.Themicrogravity
produced is an averaging of the gravity vector, if the clinostat
rotates with 40–100 rpm. Under the chosen experimental
conditions (60 rpm, 4mmpipette diameter) amaximal resid-
ual acceleration of 4 × 10−3 g is achieved at the outer radius
of the serological pipette and decreases towards the center.
The clinostat device was placed in an incubator providing
constant 37∘C. Fifteen serological pipettes rotated at the same
time with 60 rpm. 1 g controls were placed at the ground plate
of the clinostat without rotation but the same environmental
conditions are as the 𝜇g samples. The density of the cell
suspension was 0.5 × 106/mL (U937 macrophage-like cells),
0.25–0.5 × 106/mL (human primary macrophages), or 0.75 ×
106/mL (BV-2 microglial cells) in 1mL volume each. The
duration of the filling procedure was not longer than 10min
for all 30 serological pipettes. Cells were cultured in the
serological pipettes for 24 h–96 h. After clinorotation, cells
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were fixed by the addition of 500 𝜇L of 3% PFA (Sigma-
Aldrich)/2% sucrose (Sigma-Aldrich) solution for 30min,
washed with PBS and analyzed after immunocytochemical
staining by flow cytometry.
2.5. Parabolic Flights asMicrogravity Research Platform. Dur-
ing a parabolicmaneuver, an aircraft is weightless by flying on
a Keplerian trajectory, described as an unpropelled body in
ideally frictionless space subjected to a centrally symmetric
gravitational field [21]. During this free-fall trajectory, the
resultant of all forces acting on the aircraft other than
gravity is zeroed. During a flight campaign, which normally
consists of three individual flights, 31 parabolas are flown
on each flight, with 93 parabolas in total. On each parabola,
there is a period of increased gravity (1.8 g) which lasts
for 20 seconds immediately prior to and following the 20-
second period of reduced gravity (acceleration in 𝑥-, 𝑦-,
and 𝑧-axis was below 2 × 10−3 g at all times during the 𝜇g
parabola, Figure 1(a)). During the parabolic flight maneuver,
the aircraft gradually pulls up its nose and starts climbing
at an angle of approximately 45 degrees. This phase lasts
for about 20 seconds, during which the aircraft experiences
an acceleration of around 1.8 g. The engine thrust is then
reduced to the minimum required to compensate for air-
drag, and the aircraft is then in a free-fall condition, lasting
approximately for 20 seconds, during which weightlessness is
achieved. At the end of this phase, the aircraft must pull out
the parabolic arc, a maneuver which gives rise to another 20
second period to 1.8 g on the aircraft, after which it returns
to normal level flight attitude. Special designated flight areas
were above the Atlantic Ocean and the Mediterranean Sea.
Experiments were conducted during the 10th and 19th DLR
parabolic flight campaigns of the German Aerospace Center
(“Deutsches Zentrum fu¨r Luft- und Raumfahrt”, DLR) in
Bordeaux, France. The campaign used the only large aircraft
that is licensed in Europe to perform parabolic flights for
research purposes, the Airbus A300 ZERO-G.This aircraft is
a specially configured test aircraft operated by NOVESPACE
(Bordeaux, France) according to the standing orders of
NOVESPACE (A300 ZERO-G Rules and Guidelines RG-
2001-1, RG-2008-1, RG-2008-2, RG-2009-1, andRG-2009-02)
and the CEV (Centre d’essai en vol).
2.6. In-Flight Hardware for Parabolic Flight Experiments. A
custom-made hardware meeting the requirements for exper-
iments with human cell culture on board the Airbus A300
ZERO-G was developed in collaboration with KEK GmbH,
Germany (Figure 1(b)). The system has already been used
successfully for cell culture experiments during 9 parabolic
flight campaigns [18, 19].The system consists of double-sealed
cell containers holding the cells of themonocyte-macrophage
system and three experimentalmodules that supply storage of
samples before the experiment, half-automated performance
of the experiment, and storage of the processed samples.
The first module holds the cell containers at 36.5∘C in a
hanging position. From there, containers are transferred into
the second module manually. In this module, cells were fixed
by the addition of fixation reagent upon triggering. Triggering
was done manually at defined time intervals (20 sec) after
the onset of the gravitational condition of interest. The
third experimental module served as in-flight storage for the
fixated samples at 4∘C. Three samples could be processed
in parallel. Sample exchange required approximately one
minute of a defined procedure by three trained persons.
2.7. Procedures during Parabolic Flight Experiments. Trans-
port of in-flight cell culture bags in in-flight-configuration
and of fixed samples after the parabolic flight was provided
by the Swiss Air Force from Zurich to Bordeaux during each
flight day of the 13th DLR Parabolic Flight Campaign or by
train during each flight day of the 19th DLR Parabolic Flight
Campaign. After arrival at the flight location on the evening
before the flight, cells were incubated overnight at 37∘C and
handled very carefully in order to avoid any mechanical or
temperature cell stress. All steps of the entire cell preparation
and transport procedure had been tested extensively with
respect to cell viability and function beforehand. All proce-
dures during the parabolic flight campaign had been tested
several times and highly standardized following an extensive
and detailed standard protocol. During the campaign, all
procedures were documented and double-checked. In-flight
𝜇g and 1 g control experiments were performed in 200mL
Nutrimix bags [18, 19] used as in-flight cell culture bags con-
taining 3× 107 cells in 15mL.During the onset of 𝜇g or during
1 g (in-flight control experiments), 10 ng PMA/mL (with 0.01
residual DMSO) or 10 ng TNF-𝛼/mL or plain cell culture
mediumwere added to the cells. After 20 sec of 𝜇g or 1 g, cells
were fixed by addition of 1% formaldehyde (Sigma-Aldrich)
(for cytometry analysis) or lysed by RLT buffer (Qiagen)
(for RNA analysis) and cooled immediately (4∘C) during the
remaining flight. Experiments were performed at least three
times during independent flights and separate flight days.
After the flight, fixed cells were transported to the laboratories
on the same day, harvested, and subjected to analysis.
2.8. TEXUS-49 Sounding Rocket Experiment. For the
TEXUS-49 campaign at ESRANGE (Kiruna, Sweden), U937
cells were cultivated in the fully installed laboratories on site.
Cells were seeded with a density of 0.2 × 106 cells/mL and the
medium was exchanged every 48 hours as described above.
On the launch day, cells were visually inspected, harvested,
counted, and pooled to a concentration of 5 × 107 cells/mL.
0.5mL of this cell suspension was filled into a sterile 3mL
plastic syringe shortly before the launch. Additionally,
one syringe was filled with 0.3mL of cell culture medium
and another one with 1mL Trizol LS (Life Technologies,
Germany). The three syringes were mounted on a plastic
block with a tubing system connecting them. This unit was
finally integrated into the automatically operated experiment
system (Figure 1(c)). In total 35 of these experiment units
were prepared and kept at 37∘C until the integration into
the payload of the rocket. During the experimental run,
first the 0.3mL of medium, as a potential placeholder for
an activation solution, and then the 1mL of Trizol LS were
injected to the cell suspension at defined time points to lyse
the cells and preserve the current status of differential gene
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expression. Injections were performed at 75 sec after launch
to monitor a so-called baseline (BL) directly before the 𝜇g
phase, and at 375 sec after launch at the end of the 𝜇g phase.
A group of 1 g ground controls was treated immediately
after the 𝜇g sample group. TEXUS-49 consisted of a VSB-30
engine (S-30 solid rocket stage with an S-31 second stage)
and of the payload. The rocket was launched on March 29,
2011, at 06:01 am from the ESRANGE Space Center near
Kiruna, Sweden. During the ballistic suborbital flight, an
altitude of 268 km and 378 sec of microgravity with a quality
of 10−5 g were achieved.
2.9. SIMBOX Incubator System with Plunger Experiment
Insert. SIMBOX (Astrium GmbH Friedrichshafen, Ger-
many; Kayser Italia, Livorno, Italy) is a programmable, space-
qualified incubator for biological research in space equipped
with a 1 g in-flight centrifuge for 1 g control experiments. The
incubator allows for fully automatic execution of biological
experiments with limited use of commands during orbital
flight in a controlled thermal environment. The SIMBOX
incubator (internal volume 34 liters, dimensions 461 × 551 ×
273mm, empty mass 16 kg, fully integrated mass 34.5 kg,
max. power 130W) accommodates 40 experiment unique
equipment (EUEs) with 24 EUEs on the 𝜇g-platform and
16 EUEs on the 1 g-centrifuge. The plunger experiment
insert (Figure 1(d)) was developed by Astrium GmbH and
is described in the Astrium Space Biology Product Catalog
[22]. It allows medium exchange and chemical fixation of
adherent cell cultures. There are two plungers which can be
filled with any liquid and automatically activated to inject
it into the experimental volume. The EUEs consisted of a
support structure (housing made of PEEK) which includes
three culture chambers (CCs) and six supply units (SU,
plungers), two per culture compartment. Each CC has two
SUs and represents an independent loop. The CCs are closed
on the top of the housing by Specimen Slides (SS) made of
polycarbonate, on which the adherent cells were attached.
The chamber (covered by the window slide) contained the
medium. The housing is tightened by silicon sealing and
covered with an aluminum plate (cover), which is fixed
with screws. The container lid of the Biorack standard
type I container is mounted onto the housing. The Biorack
standard is based on the accommodation of various EUEs
into experiment containers which provide the interface to
facilities and support infrastructure [22]. The plunger unit is
qualified for an unmanned capsulemission and for use on the
International Space Station (ISS).
The unmanned Shenzhou-8 spacecraft was launched on
October 31, 2011, at 21:58 UTC (November 1, 2011, 05:58
LT) on board of a Long March 2F (CZ-2F) rocket from the
Jiuquan Satellite Launch Center (JSLC) in Inner Mongolia.
On November 17, the capsule was autonomously deorbited
and landed at 12:38 UTC (20:38 LT) around 500 km north
of Beijing. The SIMBOX was recovered immediately and
transported by helicopter and jet aircraft to the PITC,
Beijing. Total early retrieval time was 6 hours. On arrival
at the PITC, the SIMBOX was opened, and the EUEs
were removed and inspected. The samples were recovered
and stored in cold (4∘C) PBS until arrival in Zurich for
analysis.
2.10. SIMBOX Experiment Execution. Medium was changed
before integration of the slides into the EUEs. Inside
the EUEs, the slides were bedded in 0.5mL fully CO
2
saturated RPMI 1640 medium with 10% HS, 2mM glu-
tamine, 100U/mL penicillin, 100 𝜇g/mL streptomycin, and
250 ng/mL amphotericin B (PromoCell). Bellow 1, 3, and 5 of
the EUEs [23] were filled with RPMI 1640 medium, 10% HS,
100U/mL penicillin, 100𝜇g/mL streptomycin, 250 ng/mL
amphotericin B, 2mM glutamine, 1% PFA, and 0.6% sucrose.
Bellow 2, 4, and 6 of the EUEs [23] were filled with
PBS, 100U/mL penicillin, 100 𝜇g/mL streptomycin, and
250 ng/mL amphotericin B. Two EUEs (6 chambers) were
prepared for the 𝜇g-position, and one EUE (3 chambers) was
prepared for the 1 g position. The gravity vector of the 1 g
position was perpendicular to the surface of sample slides (𝑧-
axis). During the unpowered transport from the laboratory to
the spacecraft and installation in the spacecraft (total time 3 h
06min), the temperature was always above 21∘C. Shenzhou-8
launch was on October 31, 2011, 21:58 UTC and the spacecraft
attained orbit at 22:08 UTC. The SIMBOX timeline started
at 22:34 UTC. Active temperature control was set to 23∘C.
The centrifuge speed for the 1 g reference centrifuge was
74.40 rpm. Plungers 1, 3, and 5 of all three EUEs were
activated between 120:50:00 and 120:55:20 (hours:min:sec)
of the timeline sequences of 40 seconds. Plungers 2, 4, and
6 of all three EUSs were activated between 122:50:00 and
122:55:22 (hours:min:sec) of the timeline sequences of 40
seconds. Human macrophage-like U937 cells were cultivated
for 5 days inside the SIMBOX hardware on board of the
Shenzhou-8 spacecraft in 𝜇g and 1 g conditions, fixed with
1% PFA/sucrose solution for 2 h, and stored in PBS on board
at 23∘C until landing. After landing, the polycarbonate slides
were removed, washed, and then stored in PBS at 4∘C for
2 weeks until analysis. The ground control experiment was
executed analogously to the flight scenario. Details about the
experiment were published previously [23].
2.11. Quantification of ICAM-1 by Flow Cytometry. Surface
expression of ICAM-1 on BV-2 microglial cells and U937
monocytic and macrophage-like cells as well as primary
human macrophages was analyzed by flow cytometry. Cells
were collected from the Nutrimix bags (parabolic flight)
or standardized serological pipettes (clinorotation) fixated
in PFA/sucrose solution. After the washing procedure (PBS
without Ca/Mg, Biochrom) cells were stained with ICAM-1
monoclonal antibody (BV2: Invitrogen, FITC labeled; U937
and primarymacrophages: cell signaling, PE labeled). Analy-
sis was performed using a flow cytometer (FACSCanto II, BD
Biosciences, Heidelberg, Germany), collecting at least 20000
cells per sample.Mean fluorescence intensity Ratio (MFI)was
calculated as MFI of sample/MFI of isotype control.
2.12. ICAM-1 Analysis in BV-2 Cells from Parabolic Flight
Experiments. Cells were quadruple stained for ICAM-1,
apoptosis (TUNEL), cell delineation (HCS cell mask), and
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DNA (DAPI). In brief, cells were cytospinned onto glass
slides washed 3x with PBS, permeabilized for 1min with
0.1% Triton-X 100 (Sigma-Aldrich, Buchs, Switzerland), and
washed again 3x with PBS and incubated with the TUNEL
labeling mix (Boehringer, Mannheim, Germany) according
to themanufacturer’s instructions. For TUNEL staining, rho-
damine coupled dUTP was used. Subsequently to overnight
incubation, cells were washed again 3x with PBS, blocked
with 0.5% BSA, and stained with FITC labeled ICAM-1
antibody (BD Pharmingen, San Jose, USA) at a concentration
of 0.05mg/mL for 2 h. After additional washing, cells were
stained entirely with HCS cell mask deep red cytoplasmic
and nuclear stain (Invitrogen, Basel, Switzerland) using a
dilution of 1 : 20000 and nuclei were labeled with DAPI
(Invitrogen) at 1 𝜇g/mL for 10min. Labeled cells were imaged
using a Leica microscope DMI 6000 and LAS AF software
(Leica Microsystems, Wetzlar, Germany). For automated
imaging, the unified random sampling module was utilized,
63 randomized images of each sample were recorded, and at
least 500 single cells from 3 independent experiments from
3 different parabolas were analyzed. From each image cells
were identified according to the following criteria: nucleus
of a predefined size and brightness, being TUNEL negative,
and containingHCS staining over a certain threshold. Surface
calculation of these cells was performed with Imaris and
automated for all images using batch coordinator (Bitplane
AG, Zurich, Switzerland). Therefore, the mean intensity of
the ICAM-1 signal was analyzed in living cells exclusively
and binned into ICAM-1 intensity categories of 50 gray
levels. Statistical analysis was carried out using GraphPad
Prism software (GraphPad Software, Inc., La Jolla, USA) and
Student’s 𝑡-test was applied for all analyzed data.
2.13. ICAM-1 Analysis in Differentiated U937 Cells from
the SIMBOX Experiment. Polycarbonate slides were cut by
a water jet method into 16 T-shaped pieces. Each piece
was stained individually. In order to differentiate between
dead (necrotic/apoptotic) and living cells before fixation,
slides were stained with CellMask-deep red plasma mem-
brane stain (Invitrogen) andTUNEL reagent (Fluorescein-12-
dUTP, Roche). In addition, cells were labeled with different
mono- and polyclonal primary antibodies directed against
the cytoskeleton components and immunological relevant
surface molecules (reported in [17]) and ICAM-1 in con-
centrations according to the manufacturers’ protocols. After
blocking with 1% BSA in PBS for 1 h, primary antibodies were
detected by species specific secondary antibodies used in a
dilution of 1 : 1000 in 0.5% BSA in PBS. Secondary antibodies
were labeled with Alexa-Fluor405 or Alexa-Fluor568 (Invit-
rogen). Slide pieces were analyzed by confocal laser scanning
microscopy (Leica, SP5). Only cells positive for CellMask and
negative for TUNEL were subjected to further analysis, since
these represent the living cell population in the experiment.
Digital image analysis was performed using Imaris software
(Bitplane).
2.14. RNA Isolation from the Parabolic Flight Experiments.
After the return of the aircraft and transport of
the samples to the on-site laboratory facilities, the containers
were disassembled, the Nutrimix bags were gently agitated,
and the lysed cell solution from each bag was filled into a
T75 straight neck cell culture flask. The cell solution was
vortexed for 10 sec and passed four times through a Ø
0.8 × 120mm needle (B. Braun Melsungen, Germany) fitted
to a 50mL syringe. 50mL of absolute ethanol was added
and precipitates were resuspended by vigorous shaking.
A valve and a sterile connective piece were placed on a
Qiavac 24 plus vacuum system (Qiagen, Germany) and an
RNA maxi column (Qiagen, Germany) was attached to the
connective piece. A vacuum of −200mbar was adjusted and
the column was loaded with the lysed cell suspension. Then,
the valve was closed and the column was centrifuged at
4000 g for 3min. 15mL of buffer RW1 (Qiagen, Germany)
was applied for washing membrane bound RNA. After
centrifugation at 4000 g for 7min, the flow was discarded,
and two washing steps with 10mL RPE buffer (Qiagen,
Germany) followed each with centrifugation at 4000 g for
3min and 10min, respectively. The column bound RNA was
eluted by application of 600 𝜇L of RNase-free water (Qiagen,
Germany), incubation for 1min at room temperature, and
centrifugation for 4min at 4000 g. The elution step was
repeated with the first eluate. The RNA was transported at
approximately −150∘C in a Cryo Express dry shipper (CX-
100; Taylor-Wharton, USA) prepared with liquid nitrogen
and stored at −80∘C until the processing of the RNA for the
microarray analysis.
2.15. RNA Isolation during the TEXUS-49 Sounding Rocket
Campaign. Directly after landing, localization, and recovery
of the payload, the experiment modules were dismantled
and handed over to the scientists. The cell suspension was
sheared three times with a 20G needle (B. BraunMelsungen,
Germany) and distributed in two 2.0mL tubes. 0.1mL of
chloroform (Sigma-Aldrich, Germany) was added, and the
solution was vortexed for 15 sec and incubated for 5min
at room temperature before a 15min centrifugation step at
11000 g and 4∘C. The upper phase of both 2.0mL tubes was
transferred into a 15mL tube and 4mL of RLT buffer and
3mL of absolute ethanol were added and mixed. 4mL of
this solution was pipetted on an RNAMidi column (Qiagen,
Germany) and centrifuged for 30 sec at 3000 g at room
temperature.Theflowwas discarded, and the residual 4mLof
RNA solution was loaded on the column and centrifuged for
5min at 3000 g at room temperature.Then, the columns were
washed twice with 2.5mL of RPE buffer and centrifuged for
2min and 5min, respectively, at 3000 g and room tempera-
ture. The RNA was eluted by the addition of 250𝜇L RNase
free water (Qiagen, Germany) to the column, incubation
for 1min at room temperature, and centrifugation for 3min
at 3000 g and room temperature. The eluate was loaded
again onto the column, followed by a 1min incubation and
centrifugation for 5min at 3000 g, and room temperature.
The isolated RNAwas transferred into sterile Cryo-tubes and
stored until the return transport at approximately −150∘C
in a Cryo Express dry shipper (CX-100; Taylor-Wharton,
USA) preparedwith liquid nitrogen. After arrival in the home
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laboratory, samples were stored at −80∘C until processing the
RNA for the microarray analysis.
2.16. RNA Processing and Microarray Analysis for Parabolic
Flight and TEXUS-49 Sounding Rocket Campaign Samples.
RNA quantity and purity were analyzed spectrophotomet-
rically using a Nanodrop 1000 (Thermo Scientific). Isolated
RNA samples were all of high quality with 260/280 nm
ratios between 1.9 and 2.1. The RNA integrity was measured
using an Agilent 2100 Bioanalyzer (Agilent Technologies,
USA). Only RNA with an RNA Integrity Number (RIN) >
8.7 was used for the following microarray analysis. 400 ng
total RNA was applied to Cy3-labeling with the “Low RNA
Input Linear Amplification Kit, PLUS, One-Color” (Agilent
Tech-nologies) and hybridized for 17.5 h to a NimbleGen
expression microarray (12 × 135000 features) employing the
“Gene Expression Hybridization Kit” (Agilent Technologies,
USA). Afterwards, arrays were washed and scanned by the
Micro Array Scanner G2505B (Agilent Technologies, USA).
The image files of the scanner were analyzed with the
NimbleScan Software 2.6 using the RobustMulti-ArrayAnal-
ysis (RMA) with the default parameters. RMA, a probe-level
summarization method, identifies probes that are outliers
in the overall behavior of the expression measured for a
given gene. The contribution of outlier probes is reduced
in the reported gene expression level, which has been
demonstrated to improve the sensitivity and reproducibility
of microarray results. In addition to screening outlier probes,
NimbleScan software’s implementation of RMAused quantile
normalization and background correction. The normalized
microarray data were analyzed using Partek Genomics Suite
6.6. Statistical analysis was performed using the one-way
ANOVA and the false discovery rate (FDR) for multiple
testing corrections. Further, the coefficient of variation (CV)
expressed in percent was calculated, also known as “relative
variability,” which equals the standard deviation divided by
the mean. Genes of interest were identified and the log2
values of the measured fluorescent intensities returned by
the Partek software were back calculated to linear values.
Then, means of all values of the same gene generated by
different probes were calculated, if at least three values existed
excluding outliers. Subsequently, standard deviations were
calculated for the means and an unpaired 𝑡-test with Welch
correction was performed to test statistical significance.
2.17. Pathway Enrichment Analysis. The pathway enrichment
analysis was performed using Partek Genomics Suite 6.6 and
the KEGG human pathway library [24, 25].The𝑃 values were
calculated by the Fisher exact test. Enrichment analysis was
applied on the genes showing differential expression with 𝑃
values of <0.05 and fold change >+1.5 or < −1.5.
2.18. Statistical Analysis. Data are expressed as median or
as median ± SE. Groups contain the analysis of 200–1000
cells (SIMBOX, shown in box-plots) or data of three inde-
pendent experiments with 1–5 samples (𝑛 = 3–15, shown in
columns). Data were analyzed by one-way ANOVA followed
by Wilcoxon or unpaired 𝑡-test using GraphPad Prism 5.
∗
𝑃 < 0.1 was considered to be significant, ∗∗𝑃 < 0.05 as
significant, and ∗∗∗𝑃 < 0.01 as very significant.
3. Results
3.1. Clinorotation of Downregulated ICAM-1 Expression in
BV-2 Microglial Cells. First, we analyzed ICAM-1 expression
in BV-2 microglial cells after 24 h clinorotation (60 rpm,
4mm pipette diameter, maximal residual acceleration of 4 ×
10−3 g at the outer radius of the pipette). The clinostat device
was placed in an incubator, which provides constant 37∘C.
Fifteen serological pipettes rotated at the same time with
60 rpm. 1 g controls were placed at the ground plate of the
clinostat without rotation but with the same environment
condition like 𝜇g samples. A 1 g control group of BV-2 cells
was filled into 1mL serological pipettes in the same way as
the clinorotation cell group but was not clinorotated. Another
control group was kept at regular cell culture conditions
in the incubator (37∘C, 5% CO
2
). Cells were subsequently
stained for cell surface ICAM-1, apoptosis (TUNEL), cell
delineation (HCS CellMask), and DNA (DAPI) (Figure 2).
ICAM-1 expression analysis by flow cytometry revealed two
distinct subtypes of cells in the clinorotated group (𝜇g
group) compared to the 1 g control group and the incubator
control group consisting of only one subtype, respectively
(Figure 2(a)). The first of the two subtypes was small and
stronger granulated (subtype 1) than the second subtype,
which appears taller but less granulated (subtype 2). Apop-
totic cells were excluded from the analysis by TUNEL
staining. Subtype 1 could possibly represent an activated state.
Subtype 1 was found in the 𝜇g group as well as in the 1 g
control group, whereas the incubator control did virtually
not contain this subtype. Subtype 2 was represented in all
three cell groups, 𝜇g, 1 g control, and incubator control cell
group. However, it was primarily present in the 𝜇g and
in the incubator control group and less present in the 1 g
control group.The population distribution within cell groups
is illustrated in Figure 2(b), showing the relative cell numbers
of each population in each cell group. Since the incubator
control group consisted almost exclusively of cells in subtype
2, this number was nearly 100%, whereas subtype 1 was close
to 0%. The 𝜇g group had almost as many cells in subtype
2 as in subtype 1 with a slight predominance in subtype 2.
In Figure 2(c), the mean fluorescence intensity of the cell
subtypes in the different cell groups was depicted. While
the ICAM-1 expression in the incubator control group was
stable in both subtypes (2158 ± 234.4 RFU versus 2082 ±
171 RFU), and the 𝜇g cell group displayed significantly less
expression of ICAM-1 in subtype 1 compared to subtype 2.
ICAM-1 expression was significantly reduced in the 𝜇g group
compared to the 1 g control and the incubator control group.
Cells in the 1 g control group exhibited a similar ICAM-1
expression distribution as cells from the 𝜇g group. The mean
fluorescence intensities between subtype 2 of different groups
did not change dramatically, except a significant difference
between the 1 g control group and the incubator control
group. In summary, we suppose that ICAM-1 expression was
downregulated in microglia cells in simulated microgravity.
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Figure 2: Cytometry analysis of ICAM-1 expression in BV-2 microglial cells in simulated microgravity (2D clinorotation). BV-2 microglial
cells were exposed to either clinorotation (𝜇g), placed in the clinostat but not rotated (1 g control group), or cultured under standard cell
culture conditions (incubator control) for 24 h. Cells were stained for ICAM-1 surface expression and analyzed by flow cytometry. The level
of ICAM-1 surface expression is represented by the mean fluorescent intensity assessed by flow cytometry. (a) In forward/sideward scatter
detection mode of flow cytometry, two gates were set to separate two subtypes of BV-2 microglial cells that appeared different in size and
granulation (subtypes 1 and 2 in dot plots). (b) Distribution of BV-2 microglial cells in subtypes 1 and 2 after exposure to different gravity
conditions. (c) Quantification of ICAM-1 expression after exposure to different gravity conditions within subtypes 1 and 2. Data are given as
median ± SE (∗𝑃 < 0.1, ∗∗𝑃 < 0.05, ∗∗∗𝑃 < 0.01, 𝑛 = 3, according to one-way ANOVA followed by Wilcoxon or unpaired 𝑡-test).
3.2. Rapid and Reversible Downregulation of ICAM-1 Surface
Expression in BV-2 Microglial Cells in Real Microgravity. In
the next step, we investigated the cell surface expression of
ICAM-1 in real microgravity provided by parabolic flights
in murine BV-2 microglial cells. During parabolic flight
experiments, cells were activated at the onset of 𝜇g (or during
1 g for in-flight control experiments) by the addition of PMA
or TNF-𝛼 or not activated by the addition of medium only.
After a 20 sec period of altered gravity, cells were fixed by the
addition of formaldehyde.
During the 13th DLR parabolic flight campaign, we also
addressed the issue that, during parabolic flight experi-
ments, cells are generally subjected to irregular stress by
cell preparation and handling and by the in-flight situation
itself. This combination of interference factors always leads
to a significant degree of damaged or dead cells, which
could affect the experiment results and mask a possible
microgravity-related effect, even under presence of internal
controls. For this reason, we developed an automated analysis
method, which allows for the specific analysis of alive and
morphologically intact cells at the moment of fixation.
Experiments from different parabolas (1 g and 𝜇g, resp.)
and different flights were analyzed. The experiments were
performed in a sequence of three consecutive 𝜇g and 1 g
phases. A quadruple fluorescent staining was performed
using TUNEL (rhodamine) for detection of apoptotic cells,
DAPI for the nuclei, high content screening (HCS) CellMask
deep red for the delineation of cells, and FITC-labeled anti
ICAM-1 antibody for identification of cell surface expression
of ICAM-1. Cells were imaged with a widefield microscope
(Leica Microsystems, Wetzlar, Germany) using the uniform
random sampling module and identified by an iso-surface
calculation (Imaris, Bitplane AG, Zurich, Switzerland). This
quadruple staining allowed the exclusion of apoptotic cells
in a highly reliable fashion. An example of an apoptotic cell
and a living cell is depicted in Figure 3(a).Themean intensity
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Figure 3: ICAM-1 surface expression reacts rapidly and reversibly to microgravity. (a) Microscopy of ICAM-1, TUNEL, HCS CellMask, and
DAPI including surface calculation for HCS. In order to identify nuclei, cells were stained with DAPI (A). Apoptotic cells were identified
by TUNEL reaction (B) and HCS CellMask label (C) which can be retained to a higher extend in nonapoptotic cells. ICAM-1 intensity is
depicted in (D). A merge of TUNEL, DAPI, and ICAM-1 (E) shows an apoptotic cell (󳶣) and a living cell (→ ). The automated calculation of
an iso-surface is exclusively done for living cells using the HCS CellMask channel as shown in the merge with TUNEL, DAPI, and ICAM-1
(F). (b)–(j) BV-2 microglial cells were treated with PMA ((e), (f), and (g)) or TNF-𝛼 ((h), (i), and (j)) at the onset of microgravity or during
the 1 g in-flight control phase or left untreated ((b), (c), and (d)). Cells were fixed in flight after 20 sec normogravity (1 g) (-e-) or 20 sec
microgravity (𝜇g) (-I-). Cells were stained, imaged, and analyzed as described above. The mean intensity of the ICAM-1 signal was binned
intomean intensity fluorescence (MIF) categories and the number of cells (frequency) is plotted against these intensity categories ((b), (e), and
(h)). ICAM-1 fluorescence intensity of all analyzed cells ((c), (f), and (i)) is depicted for normogravity (triangles) and microgravity (squares).
Mean ICAM-1 fluorescence intensity of all analyzed cells ((d), (g), and (j)) was pooled for normogravity (black bar) and microgravity (open
bar). For automated imaging, the unified random sampling module was utilized and 63 randomized images of each sample were recorded
and at least 500 single cells from 3 independent experiments from 3 different parabolas were analyzed. Mean intensity and SEM are shown
and student’s 𝑡-test showed highly significant difference of the fluorescence values of ∗∗∗𝑃 < 0.0001, 𝑛 = 3.
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Figure 4: Cytometry analysis of ICAM-1 expression in macrophage-like differentiated U937 cells or primary human macrophages in
simulated microgravity (2D clinorotation). Macrophage-like differentiated U937 cells (a) or primary human macrophages (b) were exposed
to either clinorotation (𝜇g), placed in the clinostat but not rotated (1 g control group), or cultured under standard cell culture conditions
(incubator control). Cells were stained for ICAM-1 surface expression and analyzed by flow cytometry.The level of ICAM-1 surface expression
is represented by the mean fluorescent intensity assessed by flow cytometry. (a) Quantification of ICAM-1 expression in macrophage-like
differentiated U937 cells after exposure to different gravity conditions for 1 h, 3 h, or 5 h, 𝑛 = 6. (b) Quantification of ICAM-1 expression in
primary humanmacrophages after exposure to different gravity conditions for 1 h, 3 h, or 5 h, 𝑛 = 3. Data are given as median ± SE (∗𝑃 < 0.1,
∗∗
𝑃 < 0.05, ∗∗∗𝑃 < 0.01, according to one-way ANOVA followed by Wilcoxon or unpaired 𝑡-test).
of the ICAM-1 signal was analyzed in nondamaged and
nonapoptotic cells only and binned into intensity categories.
The relative frequency of these cells was plotted against the
fluorescence intensity (Figures 3(b), 3(e), and 3(h)).
We found a rapid and reversible downregulation of
ICAM-1 on the surface of BV-2 microglial cells after 20 sec
of microgravity, apparent by the frequency of cells expressing
ICAM-1 in various intensities (Figures 3(b) and 3(c)) and
the mean of ICAM-1 expression intensity (Figure 3(d)) being
only 70% in microgravity compared to normogravity. In the
presence of PMA, ICAM-1 expression was upregulated (Fig-
ures 3(e), 3(f), and 3(g)), whereas the presence of the proin-
flammatory cytokine TNF-𝛼 abrogated the microgravity-
induced ICAM-1 downregulation (Figures 3(h), 3(i), and
3(j)). Statistical analysis of all pooled data revealed downregu-
lation of ICAM-1 expression in unstimulated microglia upon
microgravity to be highly significantly different with 𝑃 <
0.001 (Figure 3(d)). Changes of ICAM-1 expression in PMA
stimulated cells were as well highly significant (Figure 3(g)),
whereas TNF-𝛼 stimulation slightly ameliorated the gravity-
dependent changes in ICAM-1 expression (Figure 3(j)).Thus,
we found a rapid and reversible disappearance of ICAM-1
protein from the cell surface in microgravity.
3.3. Increase of ICAM-1 Expression in U937 Human
Macrophage-Like Cells and Human Primary Macrophages
in Simulated Microgravity. To corroborate the relevance
of the results obtained with murine BV-2 microglial cells,
we investigated a human macrophage-like cell system.
Therefore, human monocytic U937 cells were differentiated
into macrophage-like cells [23] and humanM2 macrophages
were differentiated from blood mononuclear cells. Before
the experiment, differentiated macrophage-like cells were
detached, resuspended in fresh medium, and filled into
1mL standardized serological pipettes for the clinostat.
Clinorotation was performed for 1 d, 3 d, and 5 d. The 1 g
control group of differentiated U937 cells was filled into 1mL
serological pipettes in the same way as the clinorotation cell
group but was not rotated. Cells were subsequently fixed and
stained for cell surface ICAM-1 and apoptosis (TUNEL) to
exclude apoptotic cells from the analysis and subjected to
flow cytometry. We detected a highly significant increase
of ICAM-1 expression in the clinorotated cells (𝜇g group)
compared to the nonrotated cells (1 g control group) after 1 d
and 5 d in differentiated U937 cells (Figure 4(a)) and primary
macrophages (Figure 4(b)). However, this increase receded
after 3 and 5 days of clinorotation. Therefore, we conclude
that ICAM-1 expression is increased in human macrophages
after 1 and 5 days of simulated microgravity.
3.4. Increased ICAM-1 Expression in Differentiated U937
Cells in Real Microgravity during Parabolic Flight. During
parabolic flight experiments, we investigated rapid effects
of real microgravity on nondifferentiated and differenti-
ated U937 cells and on primary human M2-differentiated
macrophages. Nondifferentiated and differentiated myelom-
onocytic U937 cells were cultured and seeded into Nutrimix
bags as described. During the parabolicmaneuvers, cells were
activated at the onset of 𝜇g or during 1 g for in-flight control
experiments by the addition of PMA with medium in the
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case of nondifferentiated U937 cells, or not activated by the
addition of medium only in the case of differentiated U937
cells and primary macrophages. After 20 sec microgravity,
cells were fixed by the addition of paraformaldehyde. A group
of ground control cells was left in Nutrimix bags in the
laboratory incubator and activated and fixed after landing in
the same experimental equipment. Experiments from differ-
ent parabolas (1 g and 𝜇g, resp.) and different flights were
analyzed. A quadruple fluorescent staining was performed
using TUNEL (rhodamine) for detection of apoptotic cells,
DAPI for the nuclei, high content screening (HCS) CellMask
deep red for the delineation of cells, and FITC-labeled anti
ICAM-1 antibody for identification of cell surface expression
of ICAM-1.
Nondifferentiated U937 Cells. Differentiation of U937 mono-
cytic cells into macrophage-like cells significantly increased
the cell surface expression of ICAM-1 (Figure 5(a)). Non-
differentiated U937 did not demonstrate differential expres-
sion of ICAM-1 in microgravity: neither in PMA-stimulated
myelomonocytic U937 cells, nor in non-stimulated cells,
any significant alteration of ICAM-1 expression could be
detected in comparison between microgravity and 1 g condi-
tions (Figure 5(b)). The only significant difference could be
observed in nonstimulated U937 cells between the ground
control group, the 𝜇g group, and the 1 g control group.
Differences between 1 g ground and 1 g in-flight controls can
be attributed to the flight itself (e.g., vibrations, handling of
cell containers) and not to an altered gravity.
Differentiated U937 Cells. In contrast to nondifferentiated
U937 cells, macrophage-like U937 cells displayed a highly
significant gravity-dependent change in ICAM-1 expression
(Figure 5(c)). In flight, cell surface ICAM-1 was reduced dras-
tically compared to the ground control. In the microgravity
group, ICAM-1 expression was enhanced. This finding is
consistent with our experiments in simulated microgravity.
We suppose that ICAM-1 is upregulated in differentiated
macrophage-like cells in microgravity.
PrimaryMacrophages. For the analysis of primary humanM2
macrophages, double fluorescence staining was performed
using TUNEL (rhodamine) for detection of apoptotic cells
and FITC-labeled anti ICAM-1 antibody for identification
of cell surface expression of ICAM-1. Unfortunately, the 1 g
incubator control was lost during the experiment proce-
dures. Between the 1 g in-flight control and the microgravity
group, no differences in ICAM-1 surface expression could
be detected in primary human macrophages. However, due
to the technical problems and low detected expression levels
compared to primary macrophages in clinostat experiments
(see Figure 4(b)), the informative value of these results may
be limited and it is planned to repeat the parabolic flight
experiment with primary human macrophages.
3.5. Increased ICAM-1 Expression in Differentiated U937 Cells
during Long-Term Microgravity in the SIMBOX Experiment.
During the SIMBOX (Science in Microgravity Box) mis-
sion on Shenzhou-8, we investigatedmicrogravity-associated
long-term alterations inmacrophage-like differentiated U937
cells and analyzed the effect of long-term microgravity
on the cytoskeleton and immunologically relevant surface
molecules [23]. Human U937 cells were differentiated into
a macrophage-like phenotype and exposed to micrograv-
ity or 1 g on a reference centrifuge on orbit for 5 days.
The unmanned Shenzhou-8 spacecraft was launched with a
Long March 2F (CZ-2F) rocket from the Jiuquan Satellite
Launch Center (JSLC) and landed after a 17-day mission.
After on-orbit fixation, the samples were analyzed with
immunocytochemical staining and confocalmicroscopy after
landing. Double fluorescent staining was performed using
HCS CellMask deep red for the delineation of cells and
FITC-labeled anti ICAM-1 antibody for identification of
cell surface expression of ICAM-1. Cells were analyzed as
described above. We detected a significant higher expression
of ICAM-1 in long-term microgravity in comparison to
the in-flight 1 g control group (Figure 6). Similar to the
parabolic flight experiments, incubation of the macrophage-
like differentiated U937 cells in the experiment hardware
caused a significant downregulation of ICAM-1 expression.
Thus, it can be excluded that the microgravity effects on
ICAM-1 were caused by the experiment system itself.
3.6. No Influence of Altered Gravity on ICAM-1 mRNA. RNA
samples were analyzed for their quantity and quality and fur-
ther processed for the microarray hybridization on 12 × 135 K
Roche NimbleGen arrays. Data from 46 single microarrays
(19th DLR PFC: 8x 𝜇g, 6x H/W, 8x 1 g, and 6x 1.8 g; TEXUS-
49: 7x𝜇g, 6xH/W, and 5xBL)were collected, normalized, and
further analyzed. The data tables were screened for ICAM-1
values and mean fluorescence intensities including standard
deviations were calculated for all samples of one condition.
ICAM-1 shows stable expression for all gravity conditions
during the 19th DLR PFC and the TEXUS-49 campaign,
as well as for the H/W controls (Figure 7), indicating that
microgravity and hypergravity conditions did not have an
influence on mRNA ICAM-1 level in the range of 20 seconds
until 6 minutes.
3.7. PathwayAnalysis Reveals an Influence of RealMicrogravity
on the Natural Killer Cell Mediated Cytotoxicity of Monocytic
U937 Cells. Due to the wealth of data microarray analysis
provides, we were able to perform a GeneSet enrichment
analysis to identify any affected pathways or biological
networks in connection with ICAM-1 (see Supplement 1 in
the Supplementary Material available online at http://dx.doi
.org/10.1155/2015/538786). For the experiments performed
during the 19th DLR PFC with monocytic U937 cells,
we identified one significantly influenced ICAM-1 related
pathway during 20 sec of microgravity compared to the
in-flight 1 g control, namely, the natural killer cell mediated
cytotoxicity (enrichment 𝑃 value 0.0203328). For the
experiments performed on TEXUS-49 during 6min of
microgravity with monocytic U937 cells, we found two
weakly altered pathways. Specifically, the NF-kappa B
signaling pathway (enrichment 𝑃 value 0.0632651) and
the Epstein-Barr virus infection (enrichment 𝑃 value
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Figure 5: ICAM-1 expression in U937 cells, macrophage-like differentiated U937 cells, and primary human macrophages in different gravity
conditions during parabolic flight experiment. ICAM-1 expression was assessed by flow cytometry and fluorescent microscopy following
immunocytochemical staining. Cells were cultured under standard cell culture conditions (incubator control) or exposed to different gravity
conditions during the 19th DLR parabolic flight campaign. U937 cells were fixed either after PMA-activation in microgravity (𝜇g group) or
in 1 g (1 g control group). Differentiated U937 and primary macrophages were fixed after the microgravity phases (𝜇g group) or after the 1 g
phases before and after the𝜇g phase (1 g control group).The level of ICAM-1 surface expression is represented by themeanfluorescent intensity
assessed by flow cytometry. (a) ICAM-1 surface expression in myelomonocytic U937 cells (mon. U937) and macrophage-like differentiated
U937 cells (max. U937) under standard cell culture conditions. (b) ICAM-1 surface expression in U937 cells with and without activation
by PMA in different gravity conditions. (c) ICAM-1 surface expression in macrophage-like differentiated U937 cells in different gravity
conditions. (d) ICAM-1 surface expression in primary macrophages in different gravity conditions. Data are given as median ± SE (∗𝑃 < 0.1,
∗∗
𝑃 < 0.05, and ∗∗∗𝑃 < 0.01, according to one-way ANOVA followed by Wilcoxon or unpaired 𝑡-test).
0.0641782) appeared sensitive to microgravity compared to
baseline.
4. Discussion
In our study, we investigated the surface expression of
ICAM-1 protein and expression of ICAM-1 mRNA in cells
of the monocyte/macrophage system in microgravity dur-
ing clinostat, parabolic flight, sounding rocket, and orbital
experiments. In murine BV-2 microglial cells, we found
a downregulation of ICAM-1 expression in clinorotation
experiments and a rapid and reversible downregulation in
the microgravity phase of parabolic flight experiments. In
contrast, ICAM-1 expression increased in macrophage-like
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Figure 7: Influence of altered gravity during parabolic flight and sounding rocket flight on ICAM-1 mRNA expression levels. (a) ICAM-1
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differentiated human U937 cells during the micrograv-
ity phase of parabolic flights and in long-term micro-
gravity provided by a 2D clinostat or during the orbital
SIMBOX/Shenzhou-8 mission.
In nondifferentiated U937 cells, no effect of microgravity
on ICAM-1 expression could be observed during parabolic
flight experiments. A summarizing table, which presents an
overview about the cell types tested, the platforms used,
the experiment durations, analysis method, the number of
experiments, and the detected effects on ICAM-1, is demon-
strated in Table 1. In our study and according to previous
investigations [26], we detected effects of the experimental
hardware, whichwere controlled by the appropriate hardware
control experiments.
In clinostat experiments, subtype of BV-2 microglial cells
appeared in the FACS analysis of all clinostat samples (𝜇g or
1 g controls), but not at all in the incubator controls.This sub-
type consisted of smaller cells and we suppose an “activated”
phenotype of BV-2 microglial cells. It is well established that
microglial form and function are linked and that cells can
cycle reversibly from a simple rounded (activated and amoe-
boid) to a complex branched form (ramified and resting) [27].
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Thus, we assume that microgravity activates microglias cells
but downregulates ICAM-1 expression (Figure 2). Control
experiments revealed no influence of the serological pipette
incubation system on the ICAM-1 expression compared to
“normal” cell culture conditions between 1 and 5 d (data not
shown).
In this study, we also developed a method that allowed
a randomized screening of only those cells that were alive
at the fixation time point after the parabola (Figure 3).
This is of particular importance because of the damage
caused to all cells subjected to a flight experiment. Until
now, a method for analyzing only viable and nondamaged
cells obtained from flight experiments was lacking. Due
to the very limited number of samples during the exper-
iment with BV-2 cells during the 13th DLR PFC, FACS
analysis could not be utilized. We therefore developed a
microscopy based method to analyze exclusively the living
cell portion. Samples were imaged using the uniform ran-
dom sampling module of Leica LAS AF software in order
to fulfill all statistically necessary criteria of randomized
sampling. Surface calculation of cells negative for TUNEL
label under a certain threshold and positive for HCS Cell-
Mask allowed the exclusion of all apoptotic cells. The mean
ICAM-1 intensity value of each analyzed cell was taken into
account.
Modulation of the expression of surface adhesion
molecules such as ICAM-1 has been reported as the conse-
quence of long-term microgravity [28, 29]. In our study, we
found that ICAM-1 surface expression responds to gravity
changes in BV-2 microglial cells within 20 seconds. The
rapid and reversible changes of ICAM-1 on the cell surface
suggest a direct gravity-sensitive effect on the membrane
compartment or on protein folding, whereas transcriptional
or proteolytic processes are rather unlikely as they would
be too slow. Interestingly, ICAM-1 cell surface expression
in microgravity was upregulated in macrophage-like dif-
ferentiated human U937 cells (Figures 4, 5, and 7) but
downregulated in murine BV-2 microglial cells (Figure 2). In
primary humanmacrophages, no clear conclusion is possible,
because of the very low fluorescence levels in the analysis
of parabolic flight samples (Figure 5). However, the clinostat
experiments with primary human macrophages (Figure 4)
suggest an upregulation of ICAM-1 in microgravity. The
different ICAM-1 regulation between macrophage-like dif-
ferentiated human U937 and murine BV-2 microglial cells
in microgravity could be the consequence of the different
species (murine and human) or differentmolecular and func-
tional features of peripheral macrophages and CNS macro-
phages.
In our study, we detected no effect of microgravity on
ICAM-1 mRNA expression, neither in a parabolic flight
experiment, nor during the sounding rocket experiment
(Figure 7). In a previous study, also no effect of simulated
microgravity on ICAM-1 mRNA expression in endothelial
cells could be found [15]. However, performing pathway
analyses on ICAM-1 related pathways, we identified the
natural killer cell mediated cytotoxicity being influenced
significantly after 20 sec of microgravity. After 6min of
microgravity this effect appeared to be reversed and we
found the NF-kappa B signaling pathway and the Epstein-
Barr virus infection close to significant alteration. This
observation is in line with findings in astronauts after long-
term space missions where latent viruses persisting in a
dormant state after primary infection were reactivated [30,
31]. Therefore, we hypothesize that these two pathways may
be stronger affected over a longer period of microgravity. As
we were not able to find an influence on the natural killer
cell mediated cytotoxicity after 6min of microgravity, we
suppose this is one of the short-term reversible processes
that can recover after an adaptation phase to micrograv-
ity.
Related to the regulation of surface ICAM-1 expression,
internalization and receptor recycling of ICAM-1 are highly
dynamic processes [32, 33] and linked to cytoskeletal function
[34, 35].
Multiple investigators have reported that this complex
network of fibers is sensitive to environmental factors such
as microgravity and altered gravitational forces [36–38].
Several studies demonstrated modifications of the actin and
microtubule cytoskeleton in real and simulated microgravity
in lymphocytes, astrocytes, neurons, glial cells, mesenchymal
stem cells, and thyroid carcinoma cells [36–41]. Morphologi-
cal differences of both themicrotubule and actin components
of the cytoskeleton have been observed in cells grown in
real and simulatedmicrogravity [39–43]. During space flight,
actin reorganization in response to the gravity level and
abnormal assembly of actin stress fibers has been reported
[44–46].
We conclude that disturbed immune function in micro-
gravity could be a consequence of ICAM-1 modulation in
the monocyte/macrophage system, which in turn could have
a strong impact on the cells’ interaction with T lympho-
cytes and migration. An experiment under real microgravity
conditions on board of the ISS was conducted by Italian
and Swiss investigators to test the hypothesis that lack of
interaction might be the reason for the loss of activity of
T cells in microgravity [14]. The investigation consisted
of analyzing the cap formation of the adhesion proteins
LFA-1 on T cells and ICAM-1 on monocytes. The data
showed that LFA-1/ICAM-1 interactions occur in space but
are dependent on activation time; they show differences in
number, arrangement, and fluorescence intensity.Thus, LFA-
1 and ICAM-1 adhesion proteins seem to be sensitive to real
microgravity, without being altered in their interaction. Loss
of functional ICAM-1 in the brain-resident microglial cells
bears the risk of a significant impairment of the CNS immune
system. Indeed, reactivation and shed of varicella-zoster virus
(VZV) have been reported in astronauts [30, 31], a virus
which becomes latent in the nervous system after primary
infection, but is reactivated frequently in immune suppressed
individuals.
In conclusion, we found that ICAM-1 can be downreg-
ulated rapidly and reversibly in BV-2 microglial cells and
upregulated in macrophage-like differentiated U937 cells in
response to microgravity. In both cell types, long-term effects
up to several days could be detected. Thus, ICAM-1 can
be considered as a rapid-reacting and sustained gravity-
regulated molecule in mammalian cells.
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